| Name | Vebufloxacin |
|---|---|
| Synonyms |
8-(4-methyl-1-piperazinyl)-9-fluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
9-Fluoro-5-methyl-8-(4-methyl-1-piperazinyl)-6,7-dihydro-1-oxo-1H,5H-benzo<ij>quinolizine-2-carboxylic acid Flumenique Vebufloxacin //BP Benofloxacin 8-Fluoro-5,6-dihydro-4-methyl-7-(4-methyl-1-piperazinyl)-1-oxo-4H-3a-aza-1H-phenalene-2-cboxylic acid DM8966 9-Fluoro-6,7-dihydro-5-methyl-8-(4-methyl-1-piperazinyl)-1-oxo-1H,5H-benzo[ij]quinolizine-2-cboxylic acid OPC-19A 1H,5H-Benzo[ij]quinolizine-2-cboxylic acid, 9-fluoro-6,7-dihydro-5-methyl-8-(4-methyl-1-piperazinyl)-1-oxo UNII-SXI3MP1G46 1h,5h-benzo[ij]quinolizine-2-carboxylic acid,9-fluoro-6,7-dihydro-5-methyl-8-(4-methyl-1-piperazinyl)-1-oxo |
| Description | DM8966 exhibits potent antibacterial activity against gram-positive and -negative bacteria. |
|---|---|
| Related Catalog | |
| Target |
Bacteria[1] |
| In Vitro | A series of substituted 6,7-dihydro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acids is synthesized and tested for antibacterial activities. Among them, DM8966 (OPC-7241) exhibits potent antibacterial activity against gram-positive and -negative bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa, and OPC-7251 shows potent activity characteristically against Propionibacterium acnes[1]. |
| References |
| Density | 1.41g/cm3 |
|---|---|
| Boiling Point | 579.1ºC at 760 mmHg |
| Molecular Formula | C19H22FN3O3 |
| Molecular Weight | 359.39500 |
| Flash Point | 304ºC |
| Exact Mass | 359.16500 |
| PSA | 65.78000 |
| LogP | 2.10070 |
| Index of Refraction | 1.661 |